MDA-MB-468
Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells
17
IN VITRO EVALUATION OF ANTI-CANCER ACTIVITY OF KUKKUTNAKHI GUGGUL ON BREAST CANCER .......
11
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer
13
COMBINATION OF HETEROCYCLIC COMPOUNDS: AS ANTICANCER AGENTS
5
Emerging roles of low-density lipoprotein in the development and treatment of breast cancer
9
MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
10
Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3
12
MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple- negative breast cancer
14
Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion
12
Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers
62
Gigantol inhibits Wnt/β catenin signaling and exhibits anticancer activity in breast cancer cells
8
Mechanisms underlying the growth inhibitory effects of the cyclo oxygenase 2 inhibitor celecoxib in human breast cancer cells
14
Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
13
<p>Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer</p>
13
Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential
33
Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers
17
Original Article Long non-coding RNA SNHG1 promotes cell proliferation and invasion by competitively binding to miR-145 in breast cancer
8
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
14
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
11
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A–dependent phospho Akt inactivation in estrogen receptor–negative human breast cancer cells
15